Written By: Max Perelman
A lot can change in a decade.
We started 10 years ago as a venture among friends and family, each of whom was deeply and personally committed to impacting global health, each in their own way. Since then we’ve created an elite diagnostic platform, responded to a pandemic, and supplied the U.S. military with advanced testing capabilities for its fighting force.
We launched Biomeme focusing on creating a better diagnostic platform, and for 10 years we did that.
Meanwhile, the world kept turning and a lot of things changed — including science.
Antibiotics are failing because pathogens are becoming resistant to them. Climate change is putting increased stress on humans, animals, and the environment. And global pandemics aren’t confined to movie screens and comic book pages anymore, but instead are all too real.
And while things changed, so did we. We grew our team, advanced our capabilities, improved our platforms, and developed critical partnerships. We grew into a company focused on improving overall global health and established ourselves as a regional leader in advanced biotechnology.
Now, it’s time we have an updated brand that reflects our growth and our mission.
We have the same name, but we have a new 50,000 square foot headquarters, new logo, colors, and brand aesthetic that is fresh, clean, and modern — all of which is designed to match our clarified purpose-driven mission.
Meet our co-founders
We’ve accomplished a lot in ten years, and our collective purpose is now reflected in our new brand.
Our tests, technologies, and platforms offer answers on a molecular level faster than ever. So, we’ve made it our mission to fight global problems through the concept of improving One Health and combatting the interconnected health challenges facing humans, animals, plant life, waterways, and ecosystems all over the world.
We are creating our innovative Host Response test and platform with the aim of providing healthcare professionals with faster and more confident solutions in the fight against the antimicrobial resistance (AMR) crisis, all at the molecular scale. These are answers we didn’t have before.
Our next generation technology uses the body’s own host immune response to provide threat-agnostic infection diagnostics so that healthcare providers can quickly differentiate bacterial, viral, and fungal infections at the point-of-need. This information allows them to make an accurate diagnosis and offer a treatment plan that will work instead of prescribing unnecessary antibiotics. Host response shows immense capability, even at these early stages, and there’s so much more to come.
Antibiotic misuse is extremely common globally and needs to be mitigated so that antimicrobials still have their effect on patients, and our Host Response platform looks to make that a possibility.
Collaborate With Us
Since aiding in the fight against AMR and other health issues, going forward we want to ensure the incredible work we do everyday makes an optimal impact on global health.
Biomeme has three main points of focus within the new brand: Internal dynamics, market dynamics, and collaborative efforts with our partners, team members, and customers.
A new brand means new opportunities. We’re excited to tackle new challenges and remain at the cutting edge of existing wicked problems.
With our collaborators, we will remain ahead of the curve with our Host Response and AMR efforts. As a company, we will continue to promote and create new tests, technologies, and platforms.
Learn more about how we’re rising to meet the moment in protecting global health.
Regulatory Statement: Products currently under development and not approved/cleared by the FDA.
Get the latest tips from Biomeme shipped right to your inbox
As a company, we measure our progress in the diagnostics we develop and deliver and the impact we have on global health. But awards are nice, too. So we were humbled and honored to receive the PACT...